Rayyan 每月有 1,116,437 次造訪，月增率 +7.9%，定價模式為免費增值。ValueSense 每月有 8,984 次造訪，成長率 -25.4%，定價模式為免費增值。
Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
讓一般投資人也能用上對沖基金級的估值與 AI 股票分析
| 面向／指標 | | |
|---|---|---|
| 官方網域 | rayyan.ai | valuesense.io |
| 定價模式 | 免費增值 | 免費增值 |
| 每月造訪次數 | 111.64萬 (1,116,437) | 8984 (8,984) |
| 月流量變化量 | +8.19萬 (+7.9%) | -3052 (-25.4%) |
| 主要市場與市佔 | 🇺🇸 美國 (18%) | 🇺🇸 美國 (36.1%) |
| 每月直接造訪 | 67.79萬 | 3654 |
| 使用者評分 | 4.5 | 4.2 |
| 支援平台 | 網站 | 網站 |
Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
The Systematic Auto-Resolver deduplicates up to 200,000 references using your own inclusion and exclusion protocol with one click.
ResearchPilot delivers zero-shot relevance ratings, an AI Analyzer, an AI Reviewer, and auto-extraction to speed up search, screening, and data capture.
Work through title, abstract, and full-text screening with inclusion and exclusion tagging, conflict resolution, and blinded reviewer modes.
Capture structured study data with configurable extraction fields, apply PICO frameworks, and export results with auto-generated PRISMA diagrams.
讓一般投資人也能用上對沖基金級的估值與 AI 股票分析
使用反向 DCF、DCF、彼得·林奇公允價值與盈利能力價值，在買入前估算股票的真正價值。
透過 AI 驅動的預設與自訂篩選器篩選市場，並回測篩選策略以檢視其歷史表現。
瀏覽護城河股、優質成長股與被低估標的等類別下 360 多個自動產生的股票創意，並定期更新。
追蹤超級投資者的持倉以及內部人的買入與賣出，了解聰明資金的動向。
免費 / 開源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.
免費 / 開源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.
專項更強Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
專項更強Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
專項更強Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.
專項更強Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.
提供扎實的文獻搜尋與參考文獻管理工具，但缺乏 Rayyan 專門的協作篩檢介面。
專項更強Summarizes academic papers into interactive flashcards, but misses comprehensive systematic review screening pipelines.
專項更強以 AI 驅動的市場分析，讓投資決策更快、更有數據依據
